Why the study?
Does leadless pacemaker implantation provide a safe and effective pacing option in a patient with a bioprosthetic tricuspid valve and complete atrioventricular block?
Does leadless pacemaker implantation provide a safe and effective pacing option in a patient with a bioprosthetic tricuspid valve and complete atrioventricular block?
Leadless pacemaker implantation appears to be a feasible and safe option for patients with a bioprosthetic tricuspid valve who develop conduction disorders.
Supports leadless pacemaker feasibility in young congenital heart patients with post-op AVB; leaves open durability and broader applicability.
A 21-year-old man, known case of the repaired congenital heart disease, developed complete atrioventricular block (AVB) one week after simultaneous bioprosthetic pulmonary and tricuspid valve replacement and atrial septal defect repair. Considering the persistence of the AVB, it was decided to implant a permanent pacemaker. After considering all available options and the issues related to the patient, it was decided to implant a leadless pacemaker (LLP). A Micra pacemaker was implanted successfully, and the patient was discharged in good condition and without any complications. Follow-up evaluation showed appropriate LLP and bioprosthetic valve functioning. Limited prior experiences and the present report showed that LLP appears to be an ideal option in the patients with bioprosthetic tricuspid valve complicated by conduction disorders.
No takes yet. Share an insight, caveat, or question.
Mohammadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: